Chung Sun-Ku, Kim Joo-Young, Lim Joong-Yeon, Park Young Mi, Hwang Ha-Young, Nam Jae-Hwan, Park Sang Ick
Division of Intractable Diseases, Center for Biomedical Sciences, National Institute of Health, Osong Health Technology Administration Complex, 187 Osongsaengmyeo2(i)-ro, Gangoemyeon, Cheongwon-gun, Chungcheongbuk-do 363-951, Republic of Korea.
J Biomed Biotechnol. 2011;2011:636497. doi: 10.1155/2011/636497. Epub 2011 Nov 24.
Coxsackie and adenovirus receptor (CAR) was first known as a virus receptor. Recently, it is also known to have tumor suppressive activity such as inhibition of cell proliferation, migration, and invasion. It is important to understand how CAR expression can be regulated in cancers. Based on an existence of putative Sp1 binding site within CAR promoter, we investigated whether indeed Sp1 is involved in the regulation of CAR expression. We observed that deletion or mutation of Sp1 binding motif (-503/-498) prominently impaired the Sp1 binding affinity and activity of CAR promoter. Histone deacetylase inhibitor (TSA) treatment enhanced recruitment of Sp1 to the CAR promoter in ChIP assay. Meanwhile, Sp1 binding inhibitor suppressed the recruitment. Exogenous expression of wild-type Sp1 increased CAR expression in CAR-negative cells; meanwhile, dominant negative Sp1 decreased the CAR expression in CAR-positive cells. These results indicate that Sp1 is involved in regulation of CAR expression.
柯萨奇病毒和腺病毒受体(CAR)最初被认为是一种病毒受体。最近,人们还发现它具有肿瘤抑制活性,如抑制细胞增殖、迁移和侵袭。了解癌症中CAR表达如何被调控很重要。基于CAR启动子内存在假定的Sp1结合位点,我们研究了Sp1是否确实参与CAR表达的调控。我们观察到Sp1结合基序(-503/-498)的缺失或突变显著损害了Sp1与CAR启动子的结合亲和力和活性。在染色质免疫沉淀实验中,组蛋白去乙酰化酶抑制剂(TSA)处理增强了Sp1与CAR启动子的结合;同时,Sp1结合抑制剂抑制了这种结合。野生型Sp1的外源性表达增加了CAR阴性细胞中的CAR表达;同时,显性负性Sp1降低了CAR阳性细胞中的CAR表达。这些结果表明Sp1参与了CAR表达的调控。